Yu‐Sun Chang

12.8k total citations
247 papers, 9.0k citations indexed

About

Yu‐Sun Chang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yu‐Sun Chang has authored 247 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 125 papers in Molecular Biology, 103 papers in Oncology and 39 papers in Cancer Research. Recurrent topics in Yu‐Sun Chang's work include Viral-associated cancers and disorders (58 papers), RNA modifications and cancer (26 papers) and Lymphoma Diagnosis and Treatment (24 papers). Yu‐Sun Chang is often cited by papers focused on Viral-associated cancers and disorders (58 papers), RNA modifications and cancer (26 papers) and Lymphoma Diagnosis and Treatment (24 papers). Yu‐Sun Chang collaborates with scholars based in Taiwan, United States and China. Yu‐Sun Chang's co-authors include Jau‐Song Yu, Kai‐Ping Chang, Chih‐Ching Wu, Chuen Hsueh, Ying Liang, Hsin‐Pai Li, Chia‐Jung Yu, Hua‐Chien Chen, Chi‐Neu Tsai and Shih‐Tung Liu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Yu‐Sun Chang

242 papers receiving 8.9k citations

Peers

Countries citing papers authored by Yu‐Sun Chang

Since Specialization

Citations

This map shows the geographic impact of Yu‐Sun Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Sun Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Sun Chang more than expected).

Fields of papers citing papers by Yu‐Sun Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Sun Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Sun Chang. The network helps show where Yu‐Sun Chang may publish in the future.

Co-authorship network of co-authors of Yu‐Sun Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Sun Chang. A scholar is included among the top collaborators of Yu‐Sun Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Sun Chang. Yu‐Sun Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparative survival outcome of synchronous and metachronous brain metastasis from colorectal cancer: A meta‑analysis 2025 ·Oncology Letters ·Tung‐Hu Tsai, Junmin Song, Kuan‐Yu Chi, (unknown), Yu‐Sun Chang	0
2	Discovery of YJZ5118: A Potent and Highly Selective Irreversible CDK12/13 Inhibitor with Synergistic Effects in Combination with Akt Inhibition 2025 ·Journal of Medicinal Chemistry ·(unknown), Yu‐Sun Chang, (unknown), Weixue Huang, (unknown), (unknown), Wenyan Liu, Licheng Zhou, Yang Zhou, Xiaomei Ren, Rahul Mannan, Somnath Mahapatra, Yuping Zhang, (unknown), (unknown), Zhen Wang, (unknown), Arul M. Chinnaiyan, Ke Ding	0
3	The Association between Glucagon-like Peptide-1 Receptor Agonist and Major Adverse Cardiac and Cerebrovascular Events in Monoclonal Gammopathy of Undetermined Significance: A Propensity-Score Analysis 2024 ·Blood ·Junmin Song, (unknown), (unknown), Cho‐Han Chiang, (unknown), (unknown), (unknown), (unknown), Pei‐Lun Lee, Yu‐Sun Chang, Terri L. Parker, Jennifer M. Kwan, Kuan‐Yu Chi, Michael G. Nanna	1
4	Discovery of ZLC491 as a Potent, Selective, and Orally Bioavailable CDK12/13 PROTAC Degrader 2024 ·Journal of Medicinal Chemistry ·Licheng Zhou, (unknown), Yu‐Sun Chang, (unknown), (unknown), (unknown), (unknown), Rahul Mannan, Somnath Mahapatra, Ming Ding, Fengtao Zhou, Weixue Huang, Xiaomei Ren, Jian Xu, (unknown), (unknown), Zhen Wang, Arul M. Chinnaiyan, Ke Ding	8
5	Comparison between a novel salivary marker and several clinical prognosticators in oral cavity cancer 2023 ·Laryngoscope Investigative Otolaryngology ·Yi‐Chan Lee, Li‐Yu Lee, Yenlin Huang, Huang‐Kai Kao, Ya‐Ting Chang, (unknown), Johnny Chuieng‐Yi Lu, Yu‐Sun Chang, Jau‐Song Yu, Kai‐Ping Chang	2
6	HeapMS: An Automatic Peak-Picking Pipeline for Targeted Proteomic Data Powered by 2D Heatmap Transformation and Convolutional Neural Networks 2023 ·Analytical Chemistry ·Chi‐Ching Lee, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Chi Yang, Lichieh Julie Chu, Po-Jung Huang, Yuan‐Ming Yeh, Ping Tang, Yu‐Sun Chang, Jau‐Song Yu, Yen-Chang Hsiao	3
7	Urinary Metabolomic Analysis of Prostate Cancer by UPLC-FTMS and UPLC-Ion Trap MSn 2023 ·Diagnostics ·Chien‐Lun Chen, Yi‐Ting Chen, (unknown), Yu‐Sun Chang, Jau‐Song Yu, (unknown)	0
8	Combination of Epithelial Growth Factor Receptor Blockers and CDK4/6 Inhibitor for Nasopharyngeal Carcinoma Treatment 2021 ·Cancers ·Hsin‐Pai Li, Chen‐Yang Huang, Kar‐Wai Lui, Yin‐Kai Chao, Chun‐Nan Yeh, Li‐Yu Lee, Yenlin Huang, Tung‐Liang Lin, (unknown), Meiyuan Huang, (unknown), Yuan‐Ming Yeh, (unknown), (unknown), Chia‐Hsun Hsieh, Kai‐Ping Chang, Chien‐Yu Lin, Hung‐Ming Wang, Yu‐Sun Chang, Cheng‐Lung Hsu	11
9	Patterns of Human Leukocyte Antigen Class I and Class II Associations and Cancer 2020 ·Cancer Research ·Zhiwei Liu, Andriy Derkach, Kelly J. Yu, Meredith Yeager, Yu‐Sun Chang, Chien‐Jen Chen, Ulf Gyllensten, Qing Lan, Mei–Hsuan Lee, James McKay, Nathaniel Rothman, Hwai‐I Yang, Allan Hildesheim, Ruth M. Pfeiffer	16
10	Cotargeting CHK1 and PI3K Synergistically Suppresses Tumor Growth of Oral Cavity Squamous Cell Carcinoma in Patient-Derived Xenografts 2020 ·Cancers ·Chia‐Yu Yang, (unknown), Ian Yi‐Feng Chang, Chun‐Nan OuYang, Chia‐Hsun Hsieh, Yenlin Huang, Chun‐I Wang, (unknown), Wanling Wang, (unknown), Hsuan Liu, Ching‐Ping Tseng, Yu‐Sun Chang, Chih‐Ching Wu, Kai‐Ping Chang	17
11	An immuno-MALDI mass spectrometry assay for the oral cancer biomarker, matrix metalloproteinase-1, in dried saliva spot samples 2019 ·Analytica Chimica Acta ·Yen-Chang Hsiao, (unknown), Kun‐Yi Chien, (unknown), (unknown), Ya‐Ting Chang, Lang‐Ming Chi, Lichieh Julie Chu, Wei‐Fan Chiang, Chih‐Yen Chien, Kai‐Ping Chang, Yu‐Sun Chang, Jau‐Song Yu	30
12	Cytoplasmic LIF reprograms invasive mode to enhance NPC dissemination through modulating YAP1-FAK/PXN signaling 2018 ·Nature Communications ·Shu‐Chen Liu, Tien Hsu, Yu‐Sun Chang, (unknown), Shih Sheng Jiang, (unknown), Chiou‐Hwa Yuh, Chuen Hsueh, (unknown), Ngan‐Ming Tsang	29
13	High sex determining region Y-box 2 (SOX2) expression correlates with absence of nodal metastasis in esophageal squamous cell carcinoma. 2015 ·PubMed ·Wen‐Yu Chuang, Yu‐Sun Chang, Yin‐Kai Chao, Chi‐Ju Yeh, Yun‐Hen Liu, Chen‐Kan Tseng, Hsien‐Kun Chang, Yung‐Liang Wan, Chuen Hsueh	10
14	Concordant podoplanin expression in cancer-associated fibroblasts and tumor cells is an adverse prognostic factor in esophageal squamous cell carcinoma. 2014 ·PubMed ·Wen‐Yu Chuang, Chi‐Ju Yeh, Yin‐Kai Chao, Yun‐Hen Liu, Yu‐Sun Chang, Chen‐Kan Tseng, Hsien‐Kun Chang, Yung‐Liang Wan, Chuen Hsueh	11
15	Role of podoplanin expression in squamous cell carcinoma of upper aerodigestive tract. 2013 ·PubMed ·Wen‐Yu Chuang, Yu‐Sun Chang, Chi‐Ju Yeh, (unknown), Chuen Hsueh	12
16	Targeted Methylation of Two Tumor Suppressor Genes Is Sufficient to Transform Mesenchymal Stem Cells into Cancer Stem/Initiating Cells 2011 ·Cancer Research ·(unknown), Pei‐Chi Hou, Kuan‐Der Lee, Pei‐Yi Chu, Kun‐Tu Yeh, Victor X. Jin, Min‐Jen Tseng, Shaw‐Jenq Tsai, Yu‐Sun Chang, Chi‐Sheng Wu, H. Sunny Sun, Kuen‐Daw Tsai, Long‐Bin Jeng, Kenneth P. Nephew, Tim H-M. Huang, Shu‐Huei Hsiao, Yu‐Wei Leu	79
17	An Informatics-assisted Label-free Approach for Personalized Tissue Membrane Proteomics: Case Study on Colorectal Cancer 2011 ·Molecular & Cellular Proteomics ·Chia‐Li Han, Jinn-Shiun Chen, Err–Cheng Chan, (unknown), Kun‐Hsing Yu, (unknown), Chih‐Chiang Tsou, Chia-Feng Tsai, Chih-Wei Chien, (unknown), Pei-Yi Lin, Jau‐Song Yu, Chuen Hsueh, Min-Chi Chen, (unknown), Yu‐Sun Chang, Yu‐Ju Chen	51
18	Macrophage Inflammatory Protein-3α Is a Novel Serum Marker for Nasopharyngeal Carcinoma Detection and Prediction of Treatment Outcomes 2008 ·Clinical Cancer Research ·Kai‐Ping Chang, Sheng‐Po Hao, (unknown), Chih‐Ching Wu, (unknown), Yun‐Shien Lee, (unknown), Shir‐Hwa Ueng, Shiau-Chin Liu, Yu-Lun Liu, (unknown), (unknown), Yu‐Sun Chang, Jau‐Song Yu	57
19	MCP-1 Promoter Polymorphism at −2518 Is Associated with Metastasis of Nasopharyngeal Carcinoma after Treatment 2007 ·Clinical Cancer Research ·Ka‐Po Tse, (unknown), (unknown), Hsin‐Pai Li, Ying Liang, Chuen Hsueh, Kai‐Ping Chang, Jau‐Song Yu, Sheng‐Po Hao, Ling‐Ling Hsieh, Yu‐Sun Chang	50
20	Activation of DNA Methyltransferase 1 by EBV LMP1 Involves c-Jun NH2-Terminal Kinase Signaling 2006 ·Cancer Research ·(unknown), (unknown), Yen-Jung Lu, Chuen Hsueh, Ying Liang, Chi‐Long Chen, Sai Wah Tsao, (unknown), Jau‐Song Yu, Yu‐Sun Chang	197

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact